Skip to content

TMS for panic disorder

Therapeutic effect and influencing factors of transcranial magnetic stimulation assisted cognitive behavioral therapy for panic disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800020109
Enrollment
Unknown
Registered
2018-12-14
Start date
2018-12-30
Completion date
Unknown
Last updated
2018-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

panic disorder

Interventions

Group 2:Cognitive Behavior Therapy Combined with True Stimulation of TMS
Group 1:Cognitive behavioral therapy combined with TMS pseudostimulus
normal control group (not randomized):non

Sponsors

Beijing Anding Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Panic disorder patients, 50 cases, in our hospital outpatient patients. (1) Panic disorder patients who meet DSM-IV diagnostic criteria; (2) The severity of panic disorder scale scored more than 7 points; (3) Age 18-45 years old; (4) Junior high school education level above; (5) No drug treatment was given within 4 weeks; (6) Sign informed consent. 2. Normal controls, 25 healthy volunteers from the community: (1) Aged 18-45 years old, right-handed, junior high school education or above; (2) No major physical diseases or psychiatric diseases that meet the diagnostic criteria; (3) No history of mental disorders, no family history of mental disorders; (4) It does not meet the diagnostic criteria of DSM-IV axis II personality disorder; (5) It matched OCD group in gender, age, handedness and educational background; (6) Sign informed consent.

Exclusion criteria

Exclusion criteria: 1. According to the judgement of researchers, patients are at risk of suicide or injury to others; 2. History of brain organic diseases and major somatic diseases; 3. Conformity with other mental disorders such as schizophrenia and bipolar affective disorder; 4. Evidence of drug dependence and use of psychoactive substances; 5. Patients who have received electroconvulsive, transcranial magnetic stimulation, deep brain stimulation and other treatments affecting brain function in the past; 6. Those who have metal implants and dentures in vivo are in pregnancy and lactation, and have claustrophobia and other persons who can not be scanned by MRI.

Design outcomes

Secondary

MeasureTime frame
Clinical global impression, CGI;SCL-90;Personal and Social Performance Scale, PSP;VAS;

Primary

MeasureTime frame
Panic Disorder Severity Scale;Hamilton Depression Rating Scale;Hamilton Anxiety Scale, HAMA;

Countries

China

Contacts

Public ContactYang Xiangyun

Beijing Anding Hospital, Capital Medical University

wysun828@126.com+86 18810628917

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026